Skurkovich, S.V., Kislyak, N.S., Machonova, L.A. and Begunenko, S.A. (1969) Active Immunization of Children Suffering from Acute Leukaemia in Acute Phase with “Live” Allogeneic Leukaemic Cells. Nature, 223, 509-511.
 Skurkovich, S., Bulycheva, T., Mayakova, S. and Mahonova, L. (2008) Successful Immunotherapy of Acute Lymphoblastic Leukemia (ALL) in Children and Perspectives for Prevention of Solid Cancer. BIT Life Sciences’ 1st Annual World Cancer Congress, 12-15 June 2008, Shanghai, 480.
 Bulychova, T., Mayakova, S. and Skurkovich, S. (2013) Disease-Free Remission Exceeding 37 Years in Patients Treated as Children for Acute Leukemia (AL) with Immunotherapy Using Viable (Cryopreserved) Allogeneic Leukemic Cells. Journal of Cancer Research Updates, 2, 254-264.
 Davis, I.D., Chen, W., Jackson, H., et al. (2004) Recombinant NY-ESO-1 Protein with ISCOMATRIX Adjuvant Induces Broad Integrated Antibody and CD4+ and CD8+ T Cell Responses in Humans. Proceedings of the National Academy of Sciences of the USA, 101, 10697-10702.
 Lindahl, P., Leary, P. and Gresser, I. (1973) Enhancement by Interferon of the Expression of Surface Antigens on Murine Leukemia l 1210 Cells. Proceedings of the National Academy of Sciences of the USA, 70, 2785-2788.
 Skurkovich, S.V., Olshanskaya, N.V. and Eremkina, E.I. (1976) Intensification of Cellular Immune Response By immunization of Mice with the Cells Preincubated Ininterferon. Bulletin of Experimental Biology and Medicine, 82, 1230-1232.
 Linn, S. and Arber, W. (1968) Host Specificity of DNA Produced by Escherichia coli, X. In Vitro Restriction of Phage fd Replicative form. Proceedings of the National Academy of Sciences of the USA, 59, 1300-1306.